TABLE OF CONTENTS
Volume 18, Issue 8 (August 2004)
Spotlights |
Commentaries |
Molecular Targets for Therapy (MTT) |
Original Manuscripts |
Correspondence
Review
Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance FREE
A Hochhaus and P La Rosée
Leukemia 18: 1321-1331; advance online publication, June 24, 2004; doi:10.1038/sj.leu.2403426
Spotlights
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro FREE
K Cwynarski, R Laylor, E Macchiarulo, J Goldman, G Lombardi, J V Melo and F Dazzi
Leukemia 18: 1332-1339; advance online publication, June 10, 2004; doi:10.1038/sj.leu.2403401
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia FREE
C Terre, V Eclache, P Rousselot, M Imbert, C Charrin, C Gervais, M J Mozziconacci, O Maarek, H Mossafa, N Auger, N Dastugue, P Talmant, J Van den Akker, C Leonard, F N'Guyen Khac, F Mugneret, F Viguié, M Lafage-Pochitaloff, J N Bastie, G L Roux, F Nicolini, F Maloisel, N Vey, G Laurent, C Recher, M Vigier, Y Yacouben, S Giraudier, J P Vernant, B Salles, J Roussi, S Castaigne, V Leymarie, G Flandrin and M Lessard On behalf of France Intergroupe pour la Leucemie Myeloide Chronique (FILMC)
Leukemia 18: 1340-1346; advance online publication, June 10, 2004; doi:10.1038/sj.leu.2403399
Commentaries
Topoisomerase II
as a prognostic factor in mantle cell lymphoma FREE
P Korkolopoulou and T P Vassilakopoulos
Leukemia 18: 1347-1349; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403413
The first evidence of the tumor-induced angiogenesis in vivo by using the chorioallantoic membrane assay dated 1913 FREE
Domenico Ribatti
Leukemia 18: 1350-1351; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403411
Molecular Targets for Therapy (MTT)
Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate FREE
A J Tipping, S Baluch, D J Barnes, D R Veach, B M Clarkson, W G Bornmann, F X Mahon, J M Goldman and J V Melo
Leukemia 18: 1352-1356; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403416
Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro FREE
Y Satou, K Nosaka, Y Koya, J-i Yasunaga, S Toyokuni and M Matsuoka
Leukemia 18: 1357-1363; advance online publication, June 10, 2004; doi:10.1038/sj.leu.2403400
The synthetic peptide PFWT disrupts AF4–AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells FREE
R S Srinivasan, J B Nesbit, L Marrero, F Erfurth, V F LaRussa and C S Hemenway
Leukemia 18: 1364-1372; doi:10.1038/sj.leu.2403415
Original Manuscripts
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation FREE
B Rocca, R Morosetti, A Habib, N Maggiano, F Zassadowski, G Ciabattoni, C Chomienne, B Papp and F O Ranelletti
Leukemia 18: 1373-1379; advance online publication, June 10, 2004; doi:10.1038/sj.leu.2403407
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia FREE
N Feller, M A van der Pol, A van Stijn, G W D Weijers, A H Westra, B W Evertse, G J Ossenkoppele and G J Schuurhuis
Leukemia 18: 1380-1390; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403405
A sustained activation of PI3K/NF-
B pathway is critical for the survival of chronic lymphocytic leukemia B cells FREE
S Cuní, P Pérez-Aciego, G Pérez-Chacón, J A Vargas, A Sánchez, F M Martín-Saavedra, S Ballester, J García-Marco, J Jordá and A Durántez
Leukemia 18: 1391-1400; advance online publication, June 3, 2004; doi:10.1038/sj.leu.2403398
Prevalence and clinical significance of resistance to perforin- and FAS-mediated cell death in leukemia FREE
H G Otten, W G J van Ginkel, A Hagenbeek and E J Petersen
Leukemia 18: 1401-1405; advance online publication, June 24, 2004; doi:10.1038/sj.leu.2403414
Betulinic acid-induced apoptosis in leukemia cells FREE
H Ehrhardt, S Fulda, M Führer, K M Debatin and I Jeremias
Leukemia 18: 1406-1412; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403406
Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones FREE
Y Ishii, H Kiyota, S Sakai and Y Honma
Leukemia 18: 1413-1419; advance online publication, July 1, 2004; doi:10.1038/sj.leu.2403421
Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma FREE
E Terpos, M Politou, R Szydlo, E Nadal, S Avery, E Olavarria, E Kanfer, J M Goldman, J F Apperley and A Rahemtulla
Leukemia 18: 1420-1426; advance online publication, June 24, 2004; doi:10.1038/sj.leu.2403423
Correspondence
Clinical features of childhood acute myeloid leukaemia with specific gene rearrangements FREE
E Frascella, R Rondelli, M Pigazzi, C Zampieron, F Fagioli, C Favre, A A Lippi, F Locatelli, M Luciani, G Menna, C Micalizzi, C Rizzari, A M Testi, A Pession and G Basso
Leukemia 18: 1427-1429; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403410
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation FREE
C Schmid, M Schleuning, J Aschan, O Ringdén, J Hahn, E Holler, U Hegenbart, D Niederwieser, M Dugas, G Ledderose and H-J Kolb
Leukemia 18: 1430-1433; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403412
Waldenstrom's macroglobulinemia evolving into acute lymphoblastic leukemia: a case report and a review of the literature FREE
R A Madan, V T Chang, C Yook, F K Baddoura, S Srinivas and B Kasimis
Leukemia 18: 1433-1435; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403408
ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts FREE
L Mauvieux, C Helias, N Perrusson, B Lioure, N Sorel, F Brizard and M Lessard
Leukemia 18: 1436-1438; advance online publication, June 3, 2004; doi:10.1038/sj.leu.2403403
Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells: direct evidence of PI3K activation FREE
Y Kubota, H Ohnishi, A Kitanaka, T Ishida and T Tanaka
Leukemia 18: 1438-1440; advance online publication, June 3, 2004; doi:10.1038/sj.leu.2403402
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia FREE
C Beretta, G Gaipa, V Rossi, S Bernasconi, O Spinelli, M G Dell'Oro, C Rizzari, A Rambaldi, A Biondi and G Cazzaniga
Leukemia 18: 1441-1444; advance online publication, June 17, 2004; doi:10.1038/sj.leu.2403409
The paternal chromosome 9 and the maternal chromosome 22 are preferentially rearranged in chronic myeloid leukaemia FREE
R Olicio, M B Rivero and H N Seuánez
Leukemia 18: 1445-1448; advance online publication, June 10, 2004; doi:10.1038/sj.leu.2403404
